Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A quick guide helps you compare 401(k) options for your 30s, focusing on fees, employer matches, and potential tax outcomes.
24,750 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
After a dramatic fall, Canopy Growth has staged a cautious comeback. This article breaks down whether canopy growth s...
As AI and data centers expand, memory demand fuels Micron's growth. This article explains why micron technology: memo...
As investors pivot away from high-flying tech, the financial sector could offer underappreciated value. This guide ex...
When a fund exits its Brookdale Senior Living stake, it raises questions about momentum and risk. This guide breaks d...
Onto Innovation is emerging as a leading semiconductor play for 2026, rooted in its metrology and advanced packaging ...
Cardano is accelerating governance upgrades to win enterprise adoption in a stricter regulatory era. The network rati...
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
As JJSF prepares for its 2026 earnings call, investors will scrutinize margins, pricing power, and capital allocation...
This deep dive breaks down seadrill (sdrl) 2026 earnings trends, what the Q1 2026 transcript signals for the fleet an...
Rigetti Computing just reported a sharp revenue jump. This article breaks down what a tripling revenue figure could m...
Are you wondering if buying USA Rare Earth stock could lead to a million-dollar outcome? This guide breaks down the r...